Knee pain caused by osteoarthritis is suffered by millions of people worldwide10. TriVisc, a 3-injection Hyaluronic Acid , may help relieve OA-related knee pain in patients who are unresponsive to non-pharmacologic therapy and simple analgesics.
Reimbursement Code J7329
Pure11
- Highly purified HA produced by bacterial biofermentation technology
- Removes the risk of avian allergies and sensitivities
- Safe for repeat injection cycles
- Fully automated manufacturing process reduces the risk of contamination and human error
Trusted
- 35 million doses administered worldwide12†
- TriVisc efficacy established by equivalence to Visco-3 ®13
- Visco-3 determined to be non-inferior to Euflexxa®14
- Supported by published clinical data
- TriVisc exhibited improvement in WOMAC, and VAS scores compared to baseline15,16,17
35 Million doses administrated worldwide.18